European Archives - Page 3 of 1458 - European Medical Journal

alcohol consumption

Alcohol Consumption Linked to Rising Hyperuricemia Risk

Among males, rates of hyperuricaemia increased from 33.7 per 1,000 person-years in non-drinkers to 92.7 in daily drinkers consuming ≥66 g/day.

Rapid Immunotherapy Jab for Cancer Rolled Out on NHS

A new, injectable form of pembrolizumab has been rolled out on the NHS, cutting the time of treatment by up to 90%.

Semaglutide Improved Motivation in Patients with Depression

Semaglutide improved motivation in patients with major depressive disorder, holding promise for the treatment of neuropsychiatric disorders characterised by reward dysfunction.

The phrase abortion pill written in an article and highlighted

Abortion pill access upheld by Supreme Court

The remote prescription of mifepristone is under threat from a lawsuit by Louisiana.

Current Male Infertility Risk Factors Revealed

Researchers collated an updated record of male infertility risk factors in a 2026 umbrella review.

ketogenic diet

Ketogenic Diet Linked to Worse Colitis Outcomes

In this latest study, researchers showed that while the ketogenic diet maintained intestinal balance under normal conditions, it significantly exacerbated colitis when the gut lining was damaged.

Hema Now: From Stem Cells to Gene Therapy

In this episode of Hema Now, Cynthia Dunbar discusses her pioneering career in translational stem cell biology. From the evolution of…

EBMT Annual Meeting Scientific Committee Co-Chair: Antonio Pérez-Martínez

We are leaving a transition from standard treatment to personalised treatment in the clinic. We are moving from the multi-omics era to the…

Organ transplant cryopreservation

Organ Transplant Preservation Linked to Cryosolution Properties

Organ transplant cryopreservation may be influenced by solution properties, with higher glass transition temperatures linked to reduced tissue damage in experimental models.

CRISPR gene therapy

CRISPR Gene Therapy Shows Promise in Sickle Cell Disease

CRISPR gene therapy shows improved haemoglobin levels and reduced vaso occlusive events in severe sickle cell disease in early phase study data.